CNBX Pharmaceuticals, Inc. (CNBX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CNBX Pharmaceuticals Shareholders Equity (Quarterly) : -2.660M for May 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -2.660M |
| February 28, 2026 | -2.534M |
| November 30, 2025 | -2.573M |
| August 31, 2025 | -2.496M |
| May 31, 2025 | -2.537M |
| February 28, 2025 | -2.570M |
| November 30, 2024 | -2.514M |
| August 31, 2024 | -2.48M |
| May 31, 2024 | -2.454M |
| February 29, 2024 | -2.358M |
| November 30, 2023 | -2.095M |
| August 31, 2023 | -2.017M |
| May 31, 2023 | -1.909M |
| February 28, 2023 | -2.012M |
| November 30, 2022 | -1.974M |
| August 31, 2022 | -1.632M |
| May 31, 2022 | -1.182M |
| February 28, 2022 | -0.648M |
| November 30, 2021 | 0.6274M |
| August 31, 2021 | 1.806M |
| May 31, 2021 | 2.332M |
| February 28, 2021 | 3.783M |
| November 30, 2020 | 1.256M |
| August 31, 2020 | 1.764M |
| May 31, 2020 | 5.098M |
| Date | Value |
|---|---|
| February 29, 2020 | 3.152M |
| November 30, 2019 | 6.021M |
| August 31, 2019 | 14.74M |
| May 31, 2019 | 19.32M |
| February 28, 2019 | 17.97M |
| November 30, 2018 | 9.071M |
| August 31, 2018 | 2.646M |
| May 31, 2018 | 2.636M |
| February 28, 2018 | 3.248M |
| November 30, 2017 | 2.422M |
| August 31, 2017 | 2.939M |
| May 31, 2017 | 2.877M |
| February 28, 2017 | -0.2779M |
| November 30, 2016 | -0.1055M |
| August 31, 2016 | -0.4674M |
| May 31, 2016 | -0.3989M |
| February 29, 2016 | -0.3982M |
| November 30, 2015 | 0.1573M |
| August 31, 2015 | -0.3096M |
| May 31, 2015 | -0.1733M |
| February 28, 2015 | -0.0471M |
| November 30, 2014 | 0.0101M |
| August 31, 2014 | |
| May 31, 2014 | -0.0038M |
| February 28, 2014 | -0.0499M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
| Definium Therapeutics, Inc. | 918.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0128M |
| Total Liabilities (Quarterly) | 2.672M |
| Debt to Equity Ratio | -0.4388 |
| Current Ratio | 0.0048 |
| Net Debt Paydown Yield | 15.69% |